EULAR 2008 - Rheumatoid Arthritis : Anti-IL6 Therapy

The Annual European Congress of Rheumatology was held in Paris, France from June 11-14, 2008. This is the official meeting of the European League Against Rheumatism (EULAR). Full abstract reports may be can be found online by visiting the EULAR Congress website. While it is not possible to review all of the important findings from these meetings, some selected highlights are summarized. These highlights focus on Rheumatoid Arthritis. The highlights are summarized by Joan Bathon, M.D. and Jon Giles, M.D.

• OP-0131 Tocilizumab Monotherapy is Superior to Methotrexate Monotherapy in Reducing Disease Activity in Patients with Rheumatoid Arthritis: The AMBITION Study.
• OP-0251 Tocilizumab Significantly Improves Disease Outcomes in Patients with Rheumatoid Arthritis Whose Anti-TNF Therapy Failed: the RADIATE Study
  

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.